Parallax Volatility Advisers’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ICPT
MF
AAM
DM
JFG
Parallax Volatility Advisers's ICPT Position: Q2 2023 in Review
Parallax Volatility Advisers sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2023, closing a stake of 275 shares — an estimated $3.83K sold.
Parallax Volatility Advisers first reported a position in ICPT in Q4 2015 and held it in 17 quarters. The position peaked at $2.04M in Q4 2021. 126 funds tracked by Wall St. Rank hold ICPT as of Q2 2023.
- Parallax Volatility Advisers reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
- Parallax Volatility Advisers sold 275 Intercept Pharmaceuticals, Inc. shares in Q2 2023, an estimated $3.83K.
- Parallax Volatility Advisers first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2015 and held it in 17 quarters.
- Parallax Volatility Advisers's Intercept Pharmaceuticals, Inc. position peaked at $2.04M in Q4 2021.
- 126 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2023.
Based on Parallax Volatility Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.